Aequus Pharmaceuticals, Transdermal Research Pharm Laboratories LLC deal

Aequus acquired an exclusive, worldwide license to IP relating to a transdermal formulation of aripiprazole for schizophrenia from Transdermal Research. Aequus said it plans to initiate human proof-of...